These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16886908)

  • 1. Selection and characterization of an internalizing epidermal-growth-factor-receptor antibody.
    Zhao X; Dai W; Cao L; Zhu H; Yu Y; Ye Q; Wang M; Dai W; Lei P; Shen G
    Biotechnol Appl Biochem; 2007 Jan; 46(Pt 1):27-33. PubMed ID: 16886908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of tumor-specific internalizing human antibodies from phage libraries.
    Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD
    J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein.
    Conner J; Braidwood L; Brown SM
    Gene Ther; 2008 Dec; 15(24):1579-92. PubMed ID: 18701918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library.
    Heitner T; Moor A; Garrison JL; Marks C; Hasan T; Marks JD
    J Immunol Methods; 2001 Feb; 248(1-2):17-30. PubMed ID: 11223066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells.
    Jannot CB; Beerli RR; Mason S; Gullick WJ; Hynes NE
    Oncogene; 1996 Jul; 13(2):275-82. PubMed ID: 8710366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of novel EGFR-specific VHH domains.
    Gottlin EB; Xiangrong Guan ; Pegram C; Cannedy A; Campa MJ; Patz EF
    J Biomol Screen; 2009 Jan; 14(1):77-85. PubMed ID: 19171923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
    Hyland S; Beerli RR; Barbas CF; Hynes NE; Wels W
    Oncogene; 2003 Mar; 22(10):1557-67. PubMed ID: 12629519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of anti-EGFR monoclonal antibody in prostate cancer PC3 cells.
    Rezaiemanesh A; Majidi J; Baradaran B; Movasaghpour A; Nakhlband A; Barar J; Omidi Y
    Hum Antibodies; 2010; 19(2-3):63-70. PubMed ID: 20826931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
    Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
    BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human IgG antibodies recognizing distinct extracellular domains of EGF receptor exhibit different degrees of growth inhibitory effects on human A431 cancer cells.
    Chang C; Takayanagi A; Yoshida T; Shimizu N
    Exp Cell Res; 2013 May; 319(8):1146-55. PubMed ID: 23499740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of scFv-displaying phages recognizing distinct extracellular domains of EGF receptor by target-guided proximity labeling method.
    Chang C; Takayanagi A; Yoshida T; Shimizu N
    J Immunol Methods; 2011 Sep; 372(1-2):127-36. PubMed ID: 21782821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
    Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
    Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
    Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
    Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
    Friedman M; Orlova A; Johansson E; Eriksson TL; Höidén-Guthenberg I; Tolmachev V; Nilsson FY; Ståhl S
    J Mol Biol; 2008 Mar; 376(5):1388-402. PubMed ID: 18207161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
    Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
    Bioconjug Chem; 2008 Mar; 19(3):731-9. PubMed ID: 18278853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
    Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of single-chain antibody-barstar fusion in plants.
    Semenyuk EG; Stremovskiy OA; Edelweiss EF; Shirshikova OV; Balandin TG; Buryanov YI; Deyev SM
    Biochimie; 2007 Jan; 89(1):31-8. PubMed ID: 16938381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice.
    Baradaran B; Hosseini AZ; Majidi J; Farajnia S; Barar J; Saraf ZH; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(1-2):11-6. PubMed ID: 19478394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo.
    Adams TE; Koziolek EJ; Hoyne PH; Bentley JD; Lu L; Lovrecz G; Ward CW; Lee FT; Scott AM; Nash AD; Rothacker J; Nice EC; Burgess AW; Johns TG
    Growth Factors; 2009 Jun; 27(3):141-54. PubMed ID: 19333814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.